These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 26245297

  • 1. Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.
    Liu QX, Zheng H, Deng XF, Zhou D, Dai JG.
    World J Surg Oncol; 2015 Aug 07; 13():238. PubMed ID: 26245297
    [Abstract] [Full Text] [Related]

  • 2. Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer.
    Lafuente-Sanchis A, Zúñiga Á, Estors M, Martínez-Hernández NJ, Cremades A, Cuenca M, Galbis JM.
    Clin Lung Cancer; 2017 Mar 07; 18(2):e109-e116. PubMed ID: 27816393
    [Abstract] [Full Text] [Related]

  • 3. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.
    Clin Transl Oncol; 2016 Apr 07; 18(4):360-8. PubMed ID: 26307752
    [Abstract] [Full Text] [Related]

  • 4. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.
    Ann Surg Oncol; 2013 Dec 07; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [Abstract] [Full Text] [Related]

  • 5. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C, Zhu W, Qian J, He S, Wu C, Chen Y, Shu Y.
    J Thorac Oncol; 2013 Sep 07; 8(9):1163-9. PubMed ID: 23945386
    [Abstract] [Full Text] [Related]

  • 6. The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients.
    Mavridis K, Gueugnon F, Petit-Courty A, Courty Y, Barascu A, Guyetant S, Scorilas A.
    Br J Cancer; 2015 Apr 28; 112(9):1527-35. PubMed ID: 25867273
    [Abstract] [Full Text] [Related]

  • 7. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer.
    Kang MW, Lee ES, Yoon SY, Jo J, Lee J, Kim HK, Choi YS, Kim K, Shim YM, Kim J, Kim H.
    J Int Med Res; 2011 Apr 28; 39(1):78-85. PubMed ID: 21672310
    [Abstract] [Full Text] [Related]

  • 8. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L, Ai J, Long H, Liu W, Wang X, Zuo Y, Li Y, Wu Q, Deng Y.
    Oncotarget; 2016 Feb 23; 7(8):8441-54. PubMed ID: 26870998
    [Abstract] [Full Text] [Related]

  • 9. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
    Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK.
    Med Oncol; 2012 Jun 23; 29(2):618-26. PubMed ID: 21516486
    [Abstract] [Full Text] [Related]

  • 10. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H, Zeng F, Xu L, Liu X, Huang Y.
    Mol Med Rep; 2013 Nov 23; 8(5):1511-8. PubMed ID: 24008862
    [Abstract] [Full Text] [Related]

  • 11. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
    Zalewska-Ziob M, Dobija-Kubica K, Biernacki K, Adamek B, Kasperczyk J, Bruliński K, Ostrowska Z.
    Acta Biochim Pol; 2017 Nov 23; 64(4):641-646. PubMed ID: 29141053
    [Abstract] [Full Text] [Related]

  • 12. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.
    Anticancer Res; 2009 Apr 23; 29(4):1157-62. PubMed ID: 19414359
    [Abstract] [Full Text] [Related]

  • 13. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
    Warnecke-Eberz U, Bollschweiler E, Drebber U, Pohl A, Baldus SE, Hoelscher AH, Metzger R.
    Oncol Rep; 2008 Sep 23; 20(3):619-24. PubMed ID: 18695914
    [Abstract] [Full Text] [Related]

  • 14. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.
    Sanmartín E, Sirera R, Usó M, Blasco A, Gallach S, Figueroa S, Martínez N, Hernando C, Honguero A, Martorell M, Guijarro R, Rosell R, Jantus-Lewintre E, Camps C.
    Ann Surg Oncol; 2014 Feb 23; 21(2):612-20. PubMed ID: 24145997
    [Abstract] [Full Text] [Related]

  • 15. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB, Cui YG, Yao SY.
    Zhonghua Zhong Liu Za Zhi; 2008 Feb 23; 30(2):121-4. PubMed ID: 18646695
    [Abstract] [Full Text] [Related]

  • 16. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A, Yu CJ, Shun CT, Luh KT, Kuo SH, Lee YC, Yang PC.
    Int J Cancer; 2005 Jul 01; 115(4):545-55. PubMed ID: 15704107
    [Abstract] [Full Text] [Related]

  • 17. COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer.
    Bhat IA, Rasool R, Qasim I, Masoodi KZ, Paul SA, Bhat BA, Ganaie FA, Aziz SA, Shah ZA.
    Tumour Biol; 2014 Nov 01; 35(11):11209-18. PubMed ID: 25113252
    [Abstract] [Full Text] [Related]

  • 18. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
    Wang X, Sun Q, Chen C, Yin R, Huang X, Wang X, Shi R, Xu L, Ren B.
    Oncotarget; 2016 Feb 16; 7(7):8029-42. PubMed ID: 26771237
    [Abstract] [Full Text] [Related]

  • 19. Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer.
    Nicoś M, Krawczyk P, Jarosz B, Sawicki M, Michnar M, Trojanowski T, Milanowski J.
    Clin Transl Oncol; 2016 Oct 16; 18(10):1039-43. PubMed ID: 26860843
    [Abstract] [Full Text] [Related]

  • 20. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P, Li J, Yang R, Zhang F, Wang H, Chu H, Lu Y, Dun S, Wang Y, Zang W, Du Y, Chen X, Zhao G, Zhang G.
    Diagn Pathol; 2015 Jun 09; 10():63. PubMed ID: 26055877
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.